Prescient Healthcare Group

Prescient is a specialist, strategic partner to global biopharma companies. We provide expertise, derived from our extensive experience, across the drug life cycle – from the preclinical stage to loss of exclusivity and beyond. Being prescient is at the core of our strategic approach. We leverage our understanding of the past, as well as insights gathered about the dynamic present, to create game-changing perspectives that help shape the future. This is the power of prescience. Science, strategy and technology underpin our business, but it is driven by deep, collaborative relationships. As true partners, we are focused on helping clients unlock the full potential of their innovations and improve people's lives. Prescient has been a portfolio company of Bridgepoint Development Capital since 2021 and Baird Capital since 2017. For more information, please visit www.prescienthg.com.